|
EDUCATION
Harvard Law School
LL.M.
Indian Institute of Technology Kharagpur
LL.B.
Specialization in intellectual property law
Osmania University
M.Sc., Biotechnology
Osmania University
B.Sc., Genetics & Biotechnology, Zoology, Chemistry
BAR ADMISSIONS
Bar Council of Delhi
Supreme Court of Missouri
Supreme Court of New York
United States District Court for the Eastern District of Missouri
Court of Appeals for the Federal Circuit
ADDITIONAL QUALIFICATIONS
Saukshmya is a native speaker of Hindi, Tamil and Telugu.
PROFESSIONAL ACTIVITIES
Twin Cities Diversity in Practice (TCDIP) – Chair, Professional Development Committee; Former Emerging Leaders Group Representative; Professional Development Committee Member
Minnesota Asian Pacific American Bar Association (MNAPABA)
American Intellectual Property Law Association (AIPLA)
EVENTS & PUBLICATIONS
Articles & Publications Saukshmya has contributed articles to the Harvard Journal of Law and Technology Digest (JOLT), The Intellectual Property Review, Global Patent Litigation and the Multi-Jurisdictional Guide 2012: Life Sciences. Saukshmya was featured in the article, “Carlson Caspers Associates: Deliver Ingenuity to IP Clients,” Attorney at Law Magazine, May 7, 2021.
|
REPRESENTATIVE CASES
Forest Labs, et al. v. Teva Pharmaceuticals USA, Inc., et al.(memantine extended-release)
POET v. Nelson Engineering (D.S.D.)
Tsteigen, Inc. v. Viking Drill & Tool, Inc.
CommScope Technologies LLC v. Rosenberger Site Solutions, LLC et al.
Azurity Pharmaceuticals, Inc. v Annora Pharma Private Limited (Enalapril maleate)
UCB, Inc. et al. v. Annora Pharma Private Limited et al. (Brivaracetam)
Boehringer Ingelheim v. Sun (Afatinib)
Biogen International GmbH and Biogen MA Inc. v. Amneal Pharmaceuticals LLC et al. (Dimethyl fumarate)
Delcor Asset Corporation and Mylan Pharmaceuticals, Inc. v. Taro Pharmaceutical Industries Ltd., et al. (Clindamycin phosphate)
Boehringer Ingelheim v. Teva Pharmaceuticals USA, Inc., et al. (Dabigatran)